The European Medicines Agency (EMA) reports that 11 448 people in the EU have died after receiving COVID-19 vaccines.
8 368 for the Pfizer BioNTech vaccine (1 345 more than 2022);
1 579 for the AstraZeneca vaccine;.
1 161 for the Moderna vaccine;
339 for the Janssen vaccine;
1 for the Nuvaxovid vaccine;
0 for the traditional, inactivated Valneva vaccine.
The EMA notes that no causal link has been confirmed: ‘The fact that someone has had a medical issue or died after vaccination does not necessarily mean that this was caused by the vaccine.
This may have been caused, for example, by health problems not related to the vaccination.’
However, tens of thousands of doctors have reported these cases. It is impossible to rule out the possibility that these substances are responsible.
Note: Janssen vaccine?Overall, rates of reported unsolicited adverse events were similar in the vaccine and placebo groups (13.1% vs 12.0%).
Reports of embolic and thrombotic events had a slight numerical imbalance with 0.06% of vaccine recipients and 0.05% of placebo recipients reporting such events.
Concern has continued to grow over a small, but growing number of cases of a rare, but serious blood clotting disorders associated with the Johnson & Johnson coronavirus vaccine.
In May, the Food and Drug Administration (FDA) put new restrictions on who can get the J&J vaccine, based on a fresh review of data on the life-threatening blood clots that have been associated with the vaccine.
This was five months after the Centers for Disease Control and Prevention (CDC) endorsed a decision to give a preferential recommendation to the Pfizer-BioNTech and Moderna vaccines.
The latest decision restricts access of the vaccine to adults 18 and older who specifically request the J&J shot or who cannot have the other available vaccines for medical reasons.
The clotting disorder is called thrombosis with thrombocytopenia syndrome (TTS), and it is rare—an updated safety analysis showed that, as of March 18, out of more than 18 million people who got J&J, 60 cases of TTS were reported and nine people died.
The analysis was based on suspected cases of TTS reported to the government’s Vaccine Adverse Event Reporting System (VAERS).
The risk appears to be greatest—1 in 100,000—in women ages 30 to 49.
